01—Abstract
Summary
Summary of the 8-K filed November 7, 2024. Cited figures are marked; the original filing is the authoritative source.
On November 4, 2024, Xcel Energy Inc. (NASDAQ/NYSE: XEL) completed a public offering of 18,320,610 shares of common stock, with the underwriters (sold through Barclays and BofA Securities as forward sellers) subsequently exercising their full 30-day overallotment option on November 6, 2024 to purchase an additional 2,748,091 shares.
Together, the base and option shares total 21,068,701 shares, and the company entered into forward sale agreements with Barclays Bank PLC and Bank of America, N.A. covering the same aggregate number of shares. This structure means Xcel will not receive proceeds from the shares at the time of pricing; instead, it will receive cash proceeds upon settlement of the forward sale agreements at a future date, which gives the company flexibility over the timing of its equity issuance. The filing itself is largely administrative.
Its stated purpose is to file the legal opinion of Amy L. Schneider on the legality of the common stock (Exhibit 5.01), along with the Additional Forward Sale Agreements (Exhibits 10.01 and 10.02) and the XBRL cover page data (Exhibit 104), as exhibits to the Form S-3 registration statement (File No. 333-278797). The underlying Underwriting Agreement and original Forward Sale Agreements were previously reported in a Form 8-K filed November 5, 2024, and this filing incorporates those documents by reference.
For investors, the key takeaway is the scale and structure of the equity raise. Forward sales are a common tool for utilities funding large capital expenditure programs, as they allow companies to lock in pricing while deferring the dilutive impact of share issuance until settlement.
Investors should monitor the settlement timing and the forward price disclosed in subsequent filings, as well as how the proceeds are deployed against Xcel's capital plan. The filing does not disclose the offering price, net proceeds, or expected settlement date, so those details must be obtained from the Prior Form 8-K and future reports.
02—Key points
Key Highlights
- Underwriters exercised their full 30-day overallotment option on November 6, 2024, purchasing an additional 2,748,091 shares of common stock.
- Total offering size of 21,068,701 shares (18,320,610 base plus 2,748,091 option shares), covered by forward sale agreements with Barclays Bank PLC and Bank of America, N.A.
- Xcel Energy will receive proceeds upon future settlement of the forward sale agreements rather than at pricing, offering flexibility on timing of equity issuance.
- The filing is primarily administrative, filing legal opinion (Ex. 5.01), Additional Forward Sale Agreements (Ex. 10.01 and 10.02), and XBRL cover page (Ex. 104) to the existing Form S-3 (File No. 333-278797).
- Shares were registered under the previously filed Form S-3 shelf registration, so no new registration statement was required for this offering.
- Key financial terms such as offering price, forward price, expected settlement date, and net proceeds are not disclosed in this filing and must be found in the Prior Form 8-K filed November 5, 2024.
03—Questions
Frequently Asked Questions
How many shares did Xcel Energy sell in this offering, and how many were added through the overallotment option?
Xcel Energy's underwriters initially purchased 18,320,610 shares of common stock. On November 6, 2024, the underwriters exercised their 30-day option in full to buy an additional 2,748,091 shares, bringing the total offering to 21,068,701 shares.
Does Xcel Energy receive cash from this offering immediately?
Not necessarily. Because the offering was structured with forward sale agreements, Xcel Energy will receive proceeds from the forward purchasers upon future settlement of those agreements, rather than receiving cash at the time of pricing. The settlement timing is not stated in this filing.
Why did Xcel Energy use forward sale agreements instead of a standard stock issuance?
Forward sales let the company set pricing now while delaying the actual issuance and receipt of cash until a later date. This can help manage dilution timing and align equity funding with capital spending needs, which is common for capital-intensive utilities.
Who are the counterparties to the forward sale agreements?
The forward purchasers are Barclays Bank PLC and Bank of America, N.A. The forward sellers are Barclays Capital Inc. and BofA Securities, Inc., which also acted as representatives of the underwriters.
Where can investors find the full terms of the offering and agreements?
The full terms of the Underwriting Agreement and original Forward Sale Agreements are filed as exhibits to the Prior Form 8-K dated November 5, 2024. The Additional Forward Sale Agreements are filed as Exhibits 10.01 and 10.02 to this 8-K, and the legal opinion on the common stock is Exhibit 5.01.
04—Continue